urea has been researched along with Cancer of Ovary in 22 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 14 out of the 20 pts (70 %) the recurrence occurred during chemotherapy or within 6 months after the end of the chemotherapy." | 2.71 | Treatment of recurrent epithelial ovarian cancer with secondary cytoreduction and continuous intraoperative intraperitoneal hyperthermic chemoperfusion (CIIPHCP). ( Chatzigeorgiou, K; Chatzigeorgiou, N; Chrysafis, G; Dimasis, A; Economou, S; Lyratzopoulos, N; Manolas, K; Minopoulos, G; Setzis, K; Zafiriou, G, 2003) |
| "Adriamycin (doxorubicin, Adriblastin) and cis-diammine-dichloro-platinum (II) (DDP, NSC 119 875) were used in the treatment of 18 patients with ovarian carcinoma, usually after intensive pre-treatment, both in a dosage of 50 mg/m2 once every 4 weeks." | 2.64 | [Combination of adriamycin and cis-diammine-dichloro-platinum (II) in the treatment of advanced, therapy-resistant, ovarian carcinoma (author's transl)]. ( Brunner, KW; Cavalli, F; Sonntag, RW; Stoller, U; Tschopp, L, 1978) |
| " Selectivity of protection by WR2721 is probably due to the preferential formation and uptake of the thiol metabolite 2-(3-aminopropylamino)ethanethiol (WR1065), which can inactivate toxic platinum-species inside the cell." | 1.28 | Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse. ( Boven, E; Holwerda, U; Pinedo, HM; Treskes, M; van der Vijgh, WJ, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (45.45) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Gnanasekaran, KK | 1 |
| Pouland, T | 2 |
| Bunce, RA | 2 |
| Darrell Berlin, K | 1 |
| Abuskhuna, S | 1 |
| Bhandari, D | 2 |
| Mashayekhi, M | 2 |
| Zhou, DH | 1 |
| Benbrook, DM | 3 |
| Meng, Y | 1 |
| Chen, CW | 1 |
| Yung, MMH | 1 |
| Sun, W | 1 |
| Sun, J | 1 |
| Li, Z | 2 |
| Li, J | 1 |
| Zhou, W | 1 |
| Liu, SS | 1 |
| Cheung, ANY | 1 |
| Ngan, HYS | 1 |
| Braisted, JC | 1 |
| Kai, Y | 1 |
| Peng, W | 1 |
| Tzatsos, A | 1 |
| Li, Y | 1 |
| Dai, Z | 1 |
| Zheng, W | 1 |
| Chan, DW | 1 |
| Zhu, W | 1 |
| Watts, FM | 1 |
| Berlin, KD | 2 |
| Zhou, D | 1 |
| Itamochi, H | 1 |
| Nishimura, M | 1 |
| Oumi, N | 1 |
| Kato, M | 1 |
| Oishi, T | 1 |
| Shimada, M | 1 |
| Sato, S | 2 |
| Naniwa, J | 1 |
| Kudoh, A | 1 |
| Kigawa, J | 1 |
| Harada, T | 1 |
| Bryant, C | 1 |
| Rawlinson, R | 1 |
| Massey, AJ | 1 |
| Chatzigeorgiou, K | 1 |
| Economou, S | 1 |
| Chrysafis, G | 1 |
| Dimasis, A | 1 |
| Zafiriou, G | 1 |
| Setzis, K | 1 |
| Lyratzopoulos, N | 1 |
| Minopoulos, G | 1 |
| Manolas, K | 1 |
| Chatzigeorgiou, N | 1 |
| Liu, S | 1 |
| Brown, CW | 1 |
| Dhar, A | 1 |
| Guruswamy, S | 1 |
| Brown, D | 1 |
| Gardner, GJ | 1 |
| Birrer, MJ | 1 |
| Ferriss, JB | 1 |
| Brown, JJ | 1 |
| Fraser, R | 1 |
| Lever, AF | 1 |
| Robertson, JI | 1 |
| Hightower, RD | 1 |
| Sevin, BU | 1 |
| Perras, J | 1 |
| Nguyen, H | 1 |
| Angioli, R | 1 |
| Untch, M | 1 |
| Averette, H | 1 |
| Andersson, H | 1 |
| Lindegren, S | 1 |
| Bäck, T | 1 |
| Jacobsson, L | 1 |
| Leser, G | 1 |
| Horvath, G | 1 |
| Zalutsky, MR | 1 |
| Xu, FJ | 1 |
| Yu, Y | 1 |
| Foulon, CF | 1 |
| Zhao, XG | 1 |
| Slade, SK | 1 |
| Affleck, DJ | 1 |
| Bast, RC | 1 |
| Visser, GW | 1 |
| Klok, RP | 1 |
| Gebbinck, JW | 1 |
| ter Linden, T | 1 |
| van Dongen, GA | 1 |
| Molthoff, CF | 1 |
| Gerber, AC | 1 |
| Kozdrowski, I | 1 |
| Wyss, SR | 1 |
| Berger, EG | 1 |
| Cavalli, F | 1 |
| Stoller, U | 1 |
| Tschopp, L | 1 |
| Sonntag, RW | 1 |
| Brunner, KW | 1 |
| Wiltshaw, E | 1 |
| Kroner, T | 1 |
| Treskes, M | 1 |
| Boven, E | 1 |
| Holwerda, U | 1 |
| Pinedo, HM | 1 |
| van der Vijgh, WJ | 1 |
| Qian, HN | 1 |
| Feng, J | 1 |
| Fu, TY | 1 |
| Marsh, JC | 1 |
| DeConti, RC | 1 |
| Hubbard, SP | 1 |
| Rustia, M | 1 |
| McGowan, L | 1 |
| Davis, RH | 1 |
| Bunnag, B | 1 |
| Ivankovic, S | 1 |
| Black, JA | 1 |
| Chan, GF | 1 |
| Hew, CL | 1 |
| Dixon, GH | 1 |
1 review available for urea and Cancer of Ovary
| Article | Year |
|---|---|
Primary hyperaldosteronism.
Topics: Adenoma; Adolescent; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; | 1981 |
4 trials available for urea and Cancer of Ovary
| Article | Year |
|---|---|
Treatment of recurrent epithelial ovarian cancer with secondary cytoreduction and continuous intraoperative intraperitoneal hyperthermic chemoperfusion (CIIPHCP).
Topics: Disease-Free Survival; Female; Humans; Hyperthermia, Induced; Intraoperative Care; Intraoperative Pe | 2003 |
[Combination of adriamycin and cis-diammine-dichloro-platinum (II) in the treatment of advanced, therapy-resistant, ovarian carcinoma (author's transl)].
Topics: Adult; Cisplatin; Clinical Trials as Topic; Creatinine; Doxorubicin; Drug Evaluation; Drug Resistanc | 1978 |
Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Blood Platelets; Cisplatin; Drug Administration | 1976 |
Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adolescent; Adrenal Gland Neoplasms; Adult; Alkylating Agents; | 1971 |
17 other studies available for urea and Cancer of Ovary
| Article | Year |
|---|---|
Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Chromans; Female; Humans | 2020 |
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia Mutated Protein | 2018 |
Activity of oxygen-versus sulfur-containing analogs of the Flex-Het anticancer agent SHetA2.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chromans; Female; HSP70 Heat-Shock Proteins; Humans; Molecu | 2018 |
Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.
Topics: Adenocarcinoma, Clear Cell; Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resist | 2014 |
Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers.
Topics: Benzodiazepinones; Biomarkers, Tumor; Cell Line, Tumor; Checkpoint Kinase 1; Cisplatin; Deoxycytidin | 2014 |
Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Computer Simulation; Drug Screeni | 2004 |
In vitro evaluation of the novel chemotherapeutic agents U-73,975, U-77,779, and U-80,244 in gynecologic cancer cell lines.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Benzofurans; Cisplatin; Cyclohexanecarboxylic Acids; | 1993 |
Biokinetics of the monoclonal antibodies MOv 18, OV 185 and OV 197 labelled with 125I according to the m-MeATE method or the Iodogen method in nude mice with ovarian cancer xenografts.
Topics: Animals; Antibodies, Monoclonal; Benzoates; Female; Humans; Indicators and Reagents; Iodine Radioiso | 1999 |
Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution.
Topics: Animals; Antibodies, Monoclonal; Cellobiose; Female; Humans; Immunoconjugates; Iodine Radioisotopes; | 1999 |
Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.
Topics: Animals; Antibodies, Monoclonal; Carrier Proteins; Female; Folate Receptors, GPI-Anchored; Indicator | 2001 |
The charge heterogeneity of soluble human galactosyltransferases isolated from milk, amniotic fluid and malignant ascites.
Topics: Amino Acids; Amniotic Fluid; Ascites; Female; Galactosyltransferases; Humans; Hydrogen-Ion Concentra | 1979 |
Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse.
Topics: Amifostine; Animals; Cisplatin; Drug Administration Schedule; Female; Kidney; Liver; Male; Mannitol; | 1992 |
The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
Topics: Adenocarcinoma; Antibodies, Neoplasm; Antigen-Antibody Complex; Antigens, Neoplasm; Ascitic Fluid; C | 1985 |
Multiple carcinogenic effects of the ethylnitrosourea precursors ethylurea and sodium nitrite in hamsters.
Topics: Age Factors; Animals; Carcinogens; Carcinoma, Squamous Cell; Cricetinae; Female; Liver Neoplasms; Ma | 1974 |
The biochemical diagnosis of ovarian cancer.
Topics: Adenocarcinoma; Ascitic Fluid; Aspartate Aminotransferases; Bilirubin; Calcium; Cholesterol; Cystade | 1973 |
[Induction of genital cancer in pregnant rats].
Topics: Abdominal Neoplasms; Adenocarcinoma; Animals; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female | 1969 |
Gene action in the human haptoglobins. 3. Isolation of the alpha-chains as single gene products. Isolation, molecular weight, and amino acid composition of alpha and beta chains.
Topics: Acetamides; Alkylation; Amino Acids; Anhydrides; Ascitic Fluid; Carcinoma; Chemical Phenomena; Chemi | 1970 |